Endogenous angiogenesis inhibitors and their therapeutic implications.
about
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritisInhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesityAdeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationAngiostatin up-regulation in gastric cancer cell SGC7901 inhibits tumorigenesis in nude mice.Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.Endostatin gene variation and protein levels in breast cancer susceptibility and severity.Animal models of choroidal and retinal neovascularization.Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP.Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.Bioengineering strategies for designing targeted cancer therapiesApigenin and its impact on gastrointestinal cancers.κ Opioid receptor ligands regulate angiogenesis in development and in tumours.New functional roles for non-collagenous domains of basement membrane collagensTargeting Neovascularization in Ischemic Retinopathy: Recent AdvancesTissue engineering strategies for in vivo neovascularisation.Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins.What the structure of angiostatin may tell us about its mechanism of action.Gene therapy for proliferative ocular diseases.Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survivalTranslating angiogenesis research into the clinic: the challenges ahead.Inhibition of T-type Ca²⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration.Angiogenesis inhibitors found within the haemostasis pathway.Structural basis for the functions of endogenous angiogenesis inhibitors.Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy.An evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation.Development of peptides specifically modulating the activity of KLK2 and KLK3.к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling.Antiangiogenic properties of prostate-specific antigen (PSA).Novel functions for type II procollagen.Angiogenesis in gastric mucosa: an important component of gastric erosion and ulcer healing and its impairment in aging.Future options of anti-angiogenic cancer therapy.Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells.Conformational modification of serpins transforms leukocyte elastase inhibitor into an endonuclease involved in apoptosis.Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.Apoptosis induced by Na+/H+ antiport inhibition activates the LEI/L-DNase II pathway.Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis.
P2860
Q24795972-9D0B358C-9291-48E6-91DB-55AF735E2359Q26859210-913D7789-C7DB-425D-8C6D-2385BA5E416BQ31081886-58B757A4-00F6-422B-B444-74EEF11BAF54Q31123431-5C592BCD-AD0F-4446-89A7-A5DDE83FAD5EQ33245745-4E05EACC-D790-4DC2-B488-BD35C4A0EB93Q33288626-A6F5AF01-0705-4978-BF66-B633AA034423Q33582933-1D42BB36-8983-4848-BB8D-20AEA7481481Q33933658-1049252D-EB2A-4ED1-B2FF-864E35513C2DQ34166436-C5D17E98-A97E-4100-B0AA-BD69D7165A29Q34194191-B4E1F7C4-048D-46F0-9658-963512F50ED1Q34314564-76D14115-0549-4AE6-A8B6-0BBFFC11746FQ34939512-E03A617D-3081-4776-B1A0-E547011C0EA2Q34958987-E4ECF200-0C4D-4B20-85CC-113F3D13E54CQ34972210-C872B92D-4F47-4B6F-A7CA-55C6815669FAQ35040815-B34D8758-61FD-42F4-B442-57771ACEAE09Q35080616-20890499-5888-42DF-916B-1D003C4407BBQ35161745-EBECE304-1469-4A62-989A-7987A4E383AEQ35164399-4F72B585-8A83-42B2-8CF9-ACCF3BC432B8Q35626569-1A2F0FC2-0A6B-4353-9F7C-12D9E3DB506FQ35842653-2EA09C19-D983-46FC-9376-7CC476BEB93BQ35858345-900B85D6-F327-4B8B-A060-D944C939FEDAQ35904985-12526E59-D62E-4871-AB4F-AD087BC33559Q36159016-0162D228-E30F-4FB6-AF73-B9EC50AAD943Q36166483-E8C7DED8-683E-4354-AF8D-409149DF5DDEQ36547755-83461F63-FF63-49EF-98B5-94226C69C266Q36881812-D1417C57-2095-47F6-AD43-2808322319F6Q37129834-69C0C419-0A29-414B-BBB4-890E04D53B9BQ37216674-964C7D82-D19D-485D-A45B-8E2780FA5B36Q37307213-D2A06F03-E6B3-4181-BE13-66C5A59DD8A6Q37529537-036B906A-A8C7-4172-A471-A70C24CC571EQ38179467-C1062DB8-845C-4241-AE43-9FA8D7F3B71BQ38293036-534FF1ED-EFE9-4EEB-84BF-D1C4F0EA9E04Q38438425-23891047-98C0-4219-A5A6-EDBBBACF5D52Q39653387-F6536A29-6E01-4B83-8022-F5186B30FF09Q40150789-58BBB785-0998-4940-A27B-BA0F4D18605DQ40534219-4114338B-A0C5-468A-A1B9-3921A5FAF51EQ40650529-0E48D9E7-4735-4C82-BF9E-D1C6605D66DDQ40656282-E3ABCB3B-0E99-4626-82A5-FF03EEDE1A67Q42059279-B0D1E7E0-6401-4C75-9007-594CC738C587Q42217127-92F3A8E3-F88E-4655-9EC8-395A9732AF83
P2860
Endogenous angiogenesis inhibitors and their therapeutic implications.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endogenous angiogenesis inhibitors and their therapeutic implications.
@ast
Endogenous angiogenesis inhibitors and their therapeutic implications.
@en
type
label
Endogenous angiogenesis inhibitors and their therapeutic implications.
@ast
Endogenous angiogenesis inhibitors and their therapeutic implications.
@en
prefLabel
Endogenous angiogenesis inhibitors and their therapeutic implications.
@ast
Endogenous angiogenesis inhibitors and their therapeutic implications.
@en
P1476
Endogenous angiogenesis inhibitors and their therapeutic implications.
@en
P2093
P304
P356
10.1016/S1357-2725(01)00023-1
P577
2001-04-01T00:00:00Z